A new study shows young adults with higher exposure to atherogenic lipoprotein particles may be at a greater risk of ...

XyloCor Therapeutics, a clinical-stage biopharmaceutical company focused on developing novel therapies for cardiovascular disease, announced the first patient has been dosed in the Phase 2b EXACT-2 ...

Dr Amal Muthumala, consultant cardiologist at North Middlesex University Hospital and Barts Heart Centre, in London, has ...

A new study released in JAMA finds life expectancy has still not bounced back from pre-pandemic 2019 levels, attributing the ...

Nearly 1 in 3 American adolescents have prediabetes, a CDC report finds. An official notes "it’s not too late to change ...

The Association of Black Cardiologists (ABC), a national 501c3 nonprofit focused on advancing cardiovascular wellness for all ...

During the menopause transition, only 1 in 5 women have optimal scores using the American Heart Association's ...

Suddenly feeling old? Evidence now suggests that rather than a long, steady decline, we dramatically age around three ...

SGLT2 inhibitor use may help stabilize eGFR levels for patients with autosomal dominant polycystic kidney disease and type 2 diabetes, according to study data.“Given its unique pathophysiology, ...

A new study found that semaglutides like Ozempic are linked to a lower risk of Alzheimer's disease and dementia. Below, a ...

The Healthy.io, Geisinger and Boehringer Ingelheim partnership showed a 2.5x increase in test completion rates than standard clinical care.

Irregular sleep, including later sleep timing and poor continuity, was associated with increased risk for metabolic syndrome among Black adults.